CAREDX INC. DL-,001 WKN: A118WG ISIN: US14167L1035 Kürzel: CDNA Forum: Aktien Thema: Hauptdiskussion

CareDx Announces Proposed Public Offering of Common Stock https://finance.yahoo.com/news/caredx-announces-proposed-public-offering-211400257.html ...today announced that it intends to offer and sell, subject to market and other conditions, up to $175.0 million of shares of its common stock in an underwritten public offering. CareDx also expects to grant the underwriters of the offering a 30 day option to purchase up to an additional $26.25 million of shares of its of common stock offered in the public offering on the same terms and conditions. All of the shares will be offered and sold by CareDx. ...

👍

Im organ Bereich gibt es noch transmedics. Auch ein absoluter game changer. Das wird die Organspenden Revolutionieren!

CareDx Reports Preliminary Fourth Quarter and Full Year 2020 Results https://www.globenewswire.com/news-release/2021/01/11/2156127/0/en/CareDx-Reports-Preliminary-Fourth-Quarter-and-Full-Year-2020-Results.html

CareDx Agrees to Acquire TransChart and Expands EMR Connectivity to Over 90 Centers http://www.globenewswire.com/news-release/2021/01/08/2155496/0/en/CareDx-Agrees-to-Acquire-TransChart-and-Expands-EMR-Connectivity-to-Over-90-Centers.html Acquisition will build on CareDx’s digital capabilities and continue deepening the moat with transplant centers ...

CareDx Announces AlloID and Exclusive Partnership with IDbyDNA https://www.globenewswire.com/news-release/2021/01/07/2154794/0/en/CareDx-Announces-AlloID-and-Exclusive-Partnership-with-IDbyDNA.html AlloID is a Transplant Patient-Specific Metagenomic Infectious Disease Test Platform, Furthering CareDx’s Innovation in Multi-Modality Surveillance Care ...

CareDx’s AlloSeq HCT Wins Tender for French Stem Cell Transplant Patient Surveillance https://www.globenewswire.com/news-release/2021/01/04/2152520/0/en/CareDx-s-AlloSeq-HCT-Wins-Tender-for-French-Stem-Cell-Transplant-Patient-Surveillance.html CareDx wins a 2-year competitive tender with the French National Blood Service, Établissement Français du Sang ...

CareDx: Stock To Achieve Significant Long-Term Growth https://seekingalpha.com/article/4397022-caredx-stock-to-achieve-significant-long-term-growth Summary CareDx offers organ testing products that are non-invasive alternatives to more invasive traditional tests. The organ transplant market is expected to grow through 2027, creating a tailwind for CareDx. While the company's growth is strong and above-average, the valuation and near overbought level needs to be considered. ...

CareDx Celebrates the Long-Awaited Passage of the Immuno Bill http://www.globenewswire.com/news-release/2020/12/22/2149535/0/en/CareDx-Celebrates-the-Long-Awaited-Passage-of-the-Immuno-Bill.html Partners with large transplant coalition to expand access to lifesaving medications for kidney transplant patients ...

CareDx price target raised to $75 from $62 at Raymond James https://thefly.com/landingPageNews.php?id=3210563&headline=CDNA-CareDx-price-target-raised-to--from--at-Raymond-James

CareDx Announces First AlloSure Pediatrics Publication https://www.einnews.com/pr_news/531827412/caredx-announces-first-allosure-pediatrics-publication

CareDx Receives Medicare Reimbursement Pricing for AlloSure Heart https://finance.yahoo.com/news/caredx-receives-medicare-reimbursement-pricing-100000177.html

New Publication Shows CareDx’s AlloSure May Be Effective for Monitoring BK Virus in Transplant Patients https://www.globenewswire.com/news-release/2020/11/06/2121914/0/en/New-Publication-Shows-CareDx-s-AlloSure-May-Be-Effective-for-Monitoring-BK-Virus-in-Transplant-Patients.html

Bzw in Kurzform: CareDx EPS beats by $0.16, beats on revenue https://seekingalpha.com/news/3628594-caredx-eps-beats-0_16-beats-on-revenue CareDx (NASDAQ:CDNA): Q3 Non-GAAP EPS of $0.10 beats by $0.16; GAAP EPS of -$0.06 beats by $0.14. Revenue of $53.37M (+57.9% Y/Y) beats by $1.47M.

https://seekingalpha.com/pr/18065178-caredx-reports-third-quarter-2020-results?_gl=1*1vnn74t*_ga*WmNZYjIxOFBHQmxyemg5aEJpVUZNYnI5bVVGRE40RElZVE1MMFRrWFFnLVkwbm5IYXU2aUFVME1vRG9mMEV0Uw..

https://finance.yahoo.com/news/medicare-proposes-maintain-current-reimbursement-110500235.html?theme=2&_v=1&color=1&hl=en&sp=1